Skip to main content
. Author manuscript; available in PMC: 2014 Sep 21.
Published in final edited form as: Am Heart J. 2013 Jul 23;166(3):421–428. doi: 10.1016/j.ahj.2013.06.013

Table I.

Eligibility criteria

Inclusion criteria

  1. Female sex

  2. Age ≥18 y

  3. Undergoing urgent or elective PCI

  4. Undergoing diagnostic angiography for ischemic symptoms with possible PCI

  5. Ability to provide informed consent for trial participation

Exclusion criteria

  1. Peripheral arterial disease prohibiting vascular access

  2. Bilateral abnormal Barbeau tests

  3. Hemodialysis access (arteriovenous fistula or graft) in the arm to be used for PCI in case of assignment to radial approach (the opposite arm may be used for radial access if a dialysis graft is present in one arm provided that the opposite arm has a normal Barbeau test result)

  4. Valvular heart disease requiring valve surgery

  5. Planned right heart catheterization

  6. Primary PCI for STEMI

  7. Presence of bilateral internal mammary artery coronary bypass grafts

  8. Participation in investigational drug or device study currently or within 30 d before enrollment

  9. International normalized ratio ≥1.5 while treated with oral vitamin K antagonists (ie, warfarin)

  10. Receipt of oral factor Xa or IIa inhibitors ≤24 h before procedure

  11. Planned staged PCI within 30 d after index procedure